Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Development update for CFC-222

May 4, 1998

Inhibitors of HRV 2A protease discovered by Lilly

May 4, 1998

BTG licenses antifungal agents to Race Pharmaceuticals

May 4, 1998

Lymphocyte-stimulating factor and methods of treating or preventing African sleeping sickness

May 1, 1998

Low-dose oral interferon alfa: a patient-friendly treatment for chronic diseases on the horizon

April 30, 1998

Oral and parenteral formulations of levofloxacin now available in U.K.

April 30, 1998

Fujisawa outlicenses veterinary anthelmintic agent to Bayer

April 30, 1998

Cephalosporin antibiotics developed at Roche

April 29, 1998

Antibacterial amide derivatives of amythiamicin claimed by Japanese institute

April 29, 1998

Anti-MRSA carbapenems developed at Suntory

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...